Will Damron
Author
Language
English
Description
In 2015, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry signifantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fund-raising round that valued the company at more than 9 billion, putting Holmes's worth at an estimated 4.5 billion. There was just one problem:...